Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Surgical Procedures, Operative × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 10 Sarcoma 9 Neoplasms 8 Glioblastoma 8 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Esophageal Neoplasms 7 Rectal Neoplasms 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Hepatocellular 5 Recurrence 4 Prostatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Hypopharyngeal Neoplasms 4 Glioma 4 Colonic Neoplasms 4 Thyroid Neoplasms 3 Pancreatic Neoplasms 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡